Position in IDXX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$530,124
+$293,340 QoQ
Shares Held
1,007
+187.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#755
of 1,279 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Marex Group plc holds $5,474,048 across 11 Diagnostics & Research names. IDXX ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,266 | $1,136,081 | |
| 2 | DHR |
Danaher Corp /De/
|
4,403 | $838,682 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
2,551 | $578,540 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
This page
|
1,007 | $530,124 | |
| 5 | NTRA |
Natera, Inc.
|
1,705 | $462,822 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,600 | $448,000 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,801 | $381,721 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,752 | $365,548 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $530,124 | 1,007 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $236,784 | 350 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $309,468 | 577 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $317,481 | 756 | Shares | Defined | 2026-04-02 | |
| 2024-12-31 | $426,256 | 1,031 | Shares | Defined | 2026-04-02 | |
| 2024-06-30 | $10,718,400 | 22,000 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||